Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows a new revision number, updated from v3.6.5 to v3.6.6. This indicates a routine maintenance update that does not change the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:14.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was applied, updating the page's version indicator from v3.6.4. It appears to be a minor internal update rather than a substantive modification to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:43:40.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page content or its metadata.
    Difference
    0.1%
    Check dated 2026-07-25T16:47:05.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.3, replacing the previous v3.6.2 tag.
    Difference
    0.1%
    Check dated 2026-07-04T04:19:57.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page shows a new revision label v3.6.2, indicating a platform update. This update appears to change the version reference rather than the study details or text on the page.
    Difference
    0.1%
    Check dated 2026-06-27T02:50:31.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    The page now displays a recruitment status indicating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) to assist visitors. Additionally, the formatting of the Intervention/Treatment label was normalized from 'Intervention / Treatment' and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:45.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.